Difference between revisions of "Template:Hemolytic anemia DDX"

(Microangiopathic Hemolytic Anemia (MAHA))
(Microangiopathic Hemolytic Anemia (MAHA))
Line 6: Line 6:
 
*[[Heparin-Induced Thrombocytopenia (HIT)]]
 
*[[Heparin-Induced Thrombocytopenia (HIT)]]
 
*[[Hereditary spherocytosis]]
 
*[[Hereditary spherocytosis]]
*[[Paroxysmal nocturnal hemoglobinuria]]
+
*[[Paroxysmal nocturnal hemoglobinuria]] (PNH)
 
*[[Malignant hypertension]]
 
*[[Malignant hypertension]]
 
*[[Antiphospholipid syndrome]]
 
*[[Antiphospholipid syndrome]]
 
*[[Scleroderma]]
 
*[[Scleroderma]]
 
*[[Antiphospholipid Syndrome (APS)]]
 
*[[Antiphospholipid Syndrome (APS)]]
*[[Paroxysmal Nocturnal Hemoglobinuria (PNH)]]
 
 
*Other medical causes: malignancy, renal allograft rejection, vasculitides like [[polyarteritis nodosa]] and [[Wegener's granulomatosis]]
 
*Other medical causes: malignancy, renal allograft rejection, vasculitides like [[polyarteritis nodosa]] and [[Wegener's granulomatosis]]
 
*Drugs: chemotherapy; [[Clopidogrel]] (Plavix) associated with [[TTP]]
 
*Drugs: chemotherapy; [[Clopidogrel]] (Plavix) associated with [[TTP]]
 
*Nonvascular causes: prosthetic valve (more common with mechanical, more common at aortic valve), [[LVAD]], [[TIPS]], coil embolization, patched AV shunt, [[AVM]]
 
*Nonvascular causes: prosthetic valve (more common with mechanical, more common at aortic valve), [[LVAD]], [[TIPS]], coil embolization, patched AV shunt, [[AVM]]

Revision as of 17:33, 8 October 2017

Microangiopathic Hemolytic Anemia (MAHA)